By Don A Steinbrugge, Agecroft Partners – The hedge fund industry is dynamic, comprising of numerous strategies that attract varying degrees of interest over time.
Industrial metals and bulk materials stand to gain from the nascent post-Covid economic recovery according to metals and mining-focused hedge fund Delbrook Capital, while precious metals trades – an investor favourite during market uncertainty – could be starting to run
Hedge funds’ bearish bets against Cineworld suffered a dent this week as shares in the beleaguered London-listed global cinema chain – a long-standing target of short sellers – surged more than 9 per cent.
Hedge funds may be better placed to withstand a future performance squeeze in SPACs than other investors, as the recent sell-off in the asset class shed light on vehicle structures and investor-sponsor alignment. Special Purpose Acquisition Companies, or SPACs, have
The widening valuation gap between emerging markets fixed income and its developed markets counterpart is set to throw up “interesting opportunities” for EM-focused investors and hedge funds once the recent US treasury yield spike stabilises, according to BlueBay Asset Management.
Global macro hedge funds from across the emerging market, systematic and discretionary spectrum may be well-placed to capitalise on prevailing equity valuations amid economic “normalisation”, Lyxor Asset Management strategists said this week. While discretionary global macro funds offer a tactical
London-based hedge funds are warning of renewed market uncertainty, a less bullish stance on the pound and “extreme volatility” in the coming days, after EU Commission president Ursula von der Leyen and UK prime minister Boris Johnson agreed to further
Amsterdam-headquartered Privium Fund Management and London-based software provider Swarm Technology have paired up to launch Swarm XVI, a novel managed futures programme whose trading technology and quantitative investment processes mimic behaviours seen in insect colonies.
2020 has been a reminder that unforeseen circumstances can cause even the most stable of investment environments to switch quickly into being unpredictable and volatile.
The recent stock market “exuberance” sparked off by breakthroughs in Covid-19 vaccine trials may give way to disappointment next year, says Argonaut Capital CEO and CIO Barry Norris, who continues to build short positions in a number of drug companies,
